IPO Issue Details
Issue Price / Price Band₹30 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size4,000 Shares per Lot
Total Issue Size40,00,000 shares (aggregating up to ₹12.00 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenFri, 16 Jun 2023
Subscription CloseWed, 21 Jun 2023
Anchor AllotmentThu, 15 Jun 2023
Basis of AllotmentMon, 26 Jun 2023
Initiation of RefundsTue, 27 Jun 2023
Credit of Shares to DematThu, 29 Jun 2023
Listing DateFri, 30 Jun 2023
UPI Mandate Deadline2023-06-21
Application & Investment Details
Retail — Min (1 Lots)₹1,20,000 — 4,000 shares
Retail — Max (13 Lots)₹1,560,000 (13 Lots)
HNI — Min (2 Lots)₹2,40,000 — 8,000 shares
EPS (Pre-IPO)₹0.10
P/E Ratio (Pre-IPO)24.59x
Net Offer to Public37,92,000 shares (aggregating up to ₹11.38 Cr)
Reserved for Market Maker2,08,000 shares (aggregating up to ₹0.6240 Cr)
Pre-IPO Promoter Holding99,50,000 shares
Post-IPO Promoter Holding1,39,50,000 shares
About Vilin Bio Med Ltd
Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic business of manufacturing pharmaceutical products, and the manufacturing unit.The company sells its products in bulk to pharmaceutical manufacturers, marketers, and traders, who provide the channel for sales to customers.Its product list can be classified into:Oral Liquid (Syrups/Suspensions/Dry Powders (βeta & Non-βeta-Lactam).Tablets & Capsules (βeta & Non-βeta-Lactam).External Preparations.Dry Powders.The company has its R&D foundation and manufacturing facility in Roorkee, Uttarakhand.Vilin Bio Med recorded a Rs. 1,121.91 Lakhs revenue in the year 2022, and Rs. 1,171.88 Lakhs in the year 2021.
Objects of the Issue
Vilin Bio Med Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Augmenting additional working capital requirements
8.49
2
General Corporate Purposes
2.51
Shareholding & Lock-in
Pre-IPO Promoter Holding
99,50,000 shares
Post-IPO Promoter Holding
1,39,50,000 shares